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Abstract
Since its emergence in 2000, small bowel capsule 
endoscopy (SBCE) has assumed a pivotal role as an 
investigation method for small bowel diseases. The 
PillCam® SB2-ex offers 12 h of battery time, 4 more 
than the previous version (SB2). Rahman et al  recently 
found that the PillCam® SB2-ex has a significantly 
increased completion rate, although without higher 
diagnostic yield, compared with the SB2. We would 
like to discuss these somewhat surprising results and 
the new potentialities of the PillCam® SB3 regarding 
the diagnostic yield of small bowel studies. PillCam® SB3 
offers improved image resolution and faster adaptable 
frame rate over previous versions of SBCE. We recently 
compared the major duodenal papilla detection rate 
obtained with PillCam® SB3 and SB2 as a surrogate 
indicator of diagnostic yield in the proximal small 
bowel. The PillCam® SB3 had a significantly higher 
major duodenal papilla detection rate than the PillCam® SB2 
(42.7% vs  24%, P  = 0.015). Thus, the most recent 
version of the PillCam® capsule, SB3, may increase 
diagnostic yield, particularly in the proximal segments 
of the small bowel.
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Core tip: Rahman et al  recently found that the 12 
h Pil lCam® SB2-ex has a significantly increased 
completion rate, although without higher diagnostic 
yield, compared with the 8 h Pil lCam® SB2. We 
compared the major duodenal papilla detection rates 
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TO THE EDITOR
We read with great interest the paper by Rahman 
et al[1] entitled “Comparison of diagnostic yield and 
outcomes between standard 8 h capsule endoscopy 
and the new 12 h capsule endoscopy for investigating 
small bowel pathology”.
Over the last decade, many technical improvements 
in capsule endoscopy have been made in order to 
increase its diagnostic yield in small bowel studies, 
including longer battery time, wider angle of view, 
faster adaptable frame rate, and improved resolution.
The authors compared the rate of complete 
examination and diagnostic yield between the PillCam® 
SB2-ex and PillCam® SB2. The PillCam® SB2- ex offers 
12 h of battery, 4 more than the PillCam® SB2.
The authors concluded that the PillCam® SB-ex 
had a significantly higher completion rate than the 
PillCam® SB2 (88% vs 79.5%), none of the patients 
having received bowel preparation or motility agents, 
reflecting that the higher rate of complete studies is 
real.
However, they were unable to demonstrate a 
superior diagnostic yield for SB2-ex (35%) over SB2 
(48.5%). The authors suggested that this difference 
may be due to changes in the interpretation of 
results over time. However, from our point of view, 
we think that battery extension may not be the key 
issue for increasing diagnostic yield, since this can be 
compromised by rapid transit in the duodenum and 
proximal jejunum, and consequently most missed 
lesions (including mass lesions) are located in the 
proximal small-bowel[2-4]. 
The major duodenal papilla, which is present in all 
individuals who have not undergone surgery and is 
located on the medial wall of descending duodenum, 
7 to 10 cm distal to the pylorus, may be used as an 
indirect marker of a possible missed lesion in proximal 
small bowel in capsule endoscopy studies[5]. Previous 
studies have reported that the major duodenal papilla 
is missed in most of small bowel capsule endoscopy 
examinations[6].
Our experience in small bowel capsule endoscopy 
shows that the most recent version of the PillCam® capsule 
(SB3) may increase diagnostic yield, particularly in the 
proximal segments of the small bowel[7].
Indeed, the PillCam® SB3 improves image resolution 
and enables a variable frame rate, automatically 
recognizing the velocity at which it is moving and 
consequently adjusting the camera to shoot between 2 
and 6 frames per second.
Recently, we retrospectively reviewed the last 75 
cases of PillCam® SB2 examination and the first 75 
cases of PillCam® SB3 examination (up to 12 h of 
battery life) performed at our center from May 2013 to 
October 2014. The capsule endoscopic findings of the 
first tertile were reviewed at a rate of 12 images per 
second by two experienced capsule readers.
We compared the major duodenal papilla detection 
rates between the PillCam® capsule SB3 and SB2 as 
a surrogate indicator of the diagnostic yield proximal 
small bowel.
We excluded patients whose capsule was placed in 
the duodenum with endoscopic support, patients who 
underwent previous surgery, and patients with poor 
bowel preparation. None of the patients received bowel 
preparation. 
The major duodenal papilla was detected in a total 
of 50 patients (33%): 18 with SB2 (24%) and 32 
with SB3 (42.7%) (P = 0.015). The mean number 
of frames in which the major duodenal papilla was 
visualized was 7.3 (range 1-63), with no significant 
difference between the two generations of the PillCam® 
(P = 0.23) (1.7 ± 5.7 and 3.2 ± 8.5, SB2 and SB3, 
respectively).
Besides the rapid transit of the capsule through 
the duodenum and jejunum and the possibility of 
incomplete examination of the small bowel, other 
factors may also directly impair the diagnostic yield 
of capsule endoscopy, such as poor view quality, folds 
and loop angulations hiding lesions, lack of insufflation, 
and intermittent image capture[4].
Despite increased major duodenal papilla detection 
with the PillCam® SB3, higher than most studies 
reported[6], in 57% the major papilla is still not 
visualized, meaning that the risk of missing significant 
pathologies in the proximal small bowel decreased but 
was not entirely eliminated.
Nevertheless, we believe that a variable frame rate 
according to the speed of the capsule may offer real 
advantages over a longer battery life, and may be the 
way to achieve a higher diagnostic yield in small bowel 
capsule endoscopy, particularly in proximal segments 
of the small bowel, although further investigation is 
needed to validate this hypothesis.
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